Cortés-López, Mariela http://orcid.org/0000-0002-8951-4811
Schulz, Laura
Enculescu, Mihaela
Paret, Claudia http://orcid.org/0000-0002-9094-1634
Spiekermann, Bea
Quesnel-Vallières, Mathieu http://orcid.org/0000-0001-9945-8123
Torres-Diz, Manuel
Unic, Sebastian http://orcid.org/0000-0003-1671-0368
Busch, Anke http://orcid.org/0000-0002-2232-1329
Orekhova, Anna http://orcid.org/0000-0003-0450-2289
Kuban, Monika
Mesitov, Mikhail
Mulorz, Miriam M.
Shraim, Rawan
Kielisch, Fridolin http://orcid.org/0000-0003-3573-8067
Faber, Jörg
Barash, Yoseph
Thomas-Tikhonenko, Andrei
Zarnack, Kathi http://orcid.org/0000-0003-3527-3378
Legewie, Stefan http://orcid.org/0000-0003-4111-0567
König, Julian http://orcid.org/0000-0002-9398-5421
Article History
Received: 7 October 2021
Accepted: 5 July 2022
First Online: 22 September 2022
Competing interests
: A.T.-T. has an interest in intellectual property “Discovery of CD19 Spliced Isoforms Resistant to CART-19”. This interest does not meet the definition of a reviewable interest under Children’s Hospital of Philadelphia’s (CHOP’s) conflict of interest policy and is therefore not a financial conflict of interest. Furthermore, this intellectual property has not been licensed or otherwise commercialised to date. However, should this technology be commercialised in the future, A.T.-T. would be entitled to a share of royalties earned by CHOP per its patent policy. The other authors have no competing interests.